Jefferies Group LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Sep 21, 2023	SELL	$234.96 - $292.55 $2.16 Million - $2.69 Million	-9,200 Reduced 63.89%	5,200 $1.47 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $2.16 Million - $2.69 Million	-9,200 Reduced 63.89%	5,200 $1.47 Million
Q1 2022 Sep 21, 2023	SELL	$221.42 - $260.97 $14.5 Million - $17.1 Million	-65,600 Reduced 82.0%	14,400 $3.76 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $14.5 Million - $17.1 Million	-65,600 Reduced 82.0%	14,400 $3.76 Million
Q4 2021 Sep 21, 2023	BUY	$177.01 - $223.45 $3.54 Million - $4.47 Million	20,000 Added 33.33%	80,000 $17.6 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $3.54 Million - $4.47 Million	20,000 Added 33.33%	80,000 $17.6 Million
Q3 2021 Sep 21, 2023	BUY	$181.39 - $202.99 $10.3 Million - $11.6 Million	57,000 Added 1900.0%	60,000 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $10.3 Million - $11.6 Million	57,000 Added 1900.0%	60,000 $10.9 Million
Q1 2021 Sep 21, 2023	SELL	$207.02 - $241.31 $414,040 - $482,620	-2,000 Reduced 40.0%	3,000 $644,000
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $414,040 - $482,620	-2,000 Reduced 40.0%	3,000 $645,000
Q4 2020 Sep 21, 2023	SELL	$207.01 - $276.09 $41,402 - $55,217	-200 Reduced 3.85%	5,000 $1.18 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $2.09 Million - $2.79 Million	-10,100 Reduced 66.89%	5,000 $1.18 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $1.7 Million - $2.11 Million	8,500 Added 128.79%	15,100 $3.59 Million
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $983,589 - $1.32 Million	5,900 Added 842.86%	6,600 $1.45 Million
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $4.27 Million - $4.81 Million	-25,700 Reduced 97.35%	700 $119,000
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $3.42 Million - $4.32 Million	22,500 Added 576.92%	26,400 $4.38 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $1.87 Million - $2.12 Million	-13,600 Reduced 77.71%	3,900 $584,000
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $2.59 Million - $2.84 Million	17,500	17,500 $2.66 Million

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$10.7 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$9.25 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$8.51 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$4.72 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.6 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $103B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account